• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

An Epidemiological, pathological & Clinical assessment of Breast Carcinoma patients attending local secondary and tertiary care hospitals

    Dr. Dhananjay Prasad , Dr. Vinay Tiwari

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 4994-5007

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Introduction : Breast cancer is by far one of the most frequent cancer in female, both in developed and developing regions. Early diagnosis and treatment will reduce the morbidity and mortality of the disease and thus it prolongs the survival of the patient. Aim of the  study is to assess  the various type of clinical and pathological patterns of presentation of operable carcinoma breast cases in local region.
Methods: This was a  Retrospective analytical  study of 200 cases of Breast Carcinoma. Relevant clinical features like age, parity ,  laterality of the tumor, mode of presentation, history of breast cancer in 1st degree relative, fixity of the tumor and skin, and nipple-areola changes were assessed. Size, number, and location of tumor in mastectomy specimens were noted macroscopically. Microscopically, histological type, histological grade  lymphatic and blood vessel invasion, and lymph node involvement were evaluated.
Results: Most of the patient belongs to 41-50 years age group. 61% were  presented with left-sided breast Cancer. 52% presented with UOQ lump, 57%  presented with 2-5cms2 sized tumor. Maximum patients complain of Lump and Pain .Around 91% of the patients Histopathological report  showed Invasive Ductal Carcinoma. Mostly were  histological grade 3 tumors with Lympho-vascular invasion  was identified in 28%. Lymph nodes were involved in  54% cases. 41% of the patient were of  stage II B, followed by 22% with stage II A.
Conclusion: Invasive ductal carcinoma (IDC), not otherwise specified (NOS), is the most common histologic type. Its frequency of occurrence far exceeds that of the other histological types. Most commonly affected age group by breast cancer is 41-50 years, and most of the patients are from post-menopausal age group. Size of the mass was more than 2 cm involving multiple quadrants of breast and with positive lymph nodes. Histologically, grade 3 tumor is most prevalent in study population. Stage II A & II B Comprise maximum patients . 
Keywords:
    Breast Cancer Invasive Ductal Carcinoma retrospective grade management
  • PDF (709 K)
  • XML
(2022). An Epidemiological, pathological & Clinical assessment of Breast Carcinoma patients attending local secondary and tertiary care hospitals. European Journal of Molecular & Clinical Medicine, 9(7), 4994-5007.
Dr. Dhananjay Prasad , Dr. Vinay Tiwari. "An Epidemiological, pathological & Clinical assessment of Breast Carcinoma patients attending local secondary and tertiary care hospitals". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 4994-5007.
(2022). 'An Epidemiological, pathological & Clinical assessment of Breast Carcinoma patients attending local secondary and tertiary care hospitals', European Journal of Molecular & Clinical Medicine, 9(7), pp. 4994-5007.
An Epidemiological, pathological & Clinical assessment of Breast Carcinoma patients attending local secondary and tertiary care hospitals. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 4994-5007.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 18
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus